Øystein Kalsnes Jørstad

772 total citations · 1 hit paper
49 papers, 465 citations indexed

About

Øystein Kalsnes Jørstad is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Neurology. According to data from OpenAlex, Øystein Kalsnes Jørstad has authored 49 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Ophthalmology, 20 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Neurology. Recurrent topics in Øystein Kalsnes Jørstad's work include Retinal Diseases and Treatments (17 papers), Retinal and Optic Conditions (12 papers) and Retinal Imaging and Analysis (9 papers). Øystein Kalsnes Jørstad is often cited by papers focused on Retinal Diseases and Treatments (17 papers), Retinal and Optic Conditions (12 papers) and Retinal Imaging and Analysis (9 papers). Øystein Kalsnes Jørstad collaborates with scholars based in Norway, Croatia and United Kingdom. Øystein Kalsnes Jørstad's co-authors include Morten C. Moe, Ragnheiður Bragadóttir, Goran Petrovski, Per Kristian Eide, Tiril Sandell, Andrzej Grzybowski, Geir Ringstad, Jan Terje Andersen, Stian Foss and Torleif Tollefsrud Gjølberg and has published in prestigious journals such as Scientific Reports, International Journal of Environmental Research and Public Health and Investigative Ophthalmology & Visual Science.

In The Last Decade

Øystein Kalsnes Jørstad

40 papers receiving 451 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of semaglutide and risk of non‐arteritic anterior ischemic optic neuropathy: A Danish–Norwegian cohort study

2025 14 citations Lars Christian Lund, Martin Ernst et al. Diabetes Obesity and Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Øystein Kalsnes Jørstad Norway	12	297	170	63	63	42	49	465
Phoebe D. Lenhart United States	12	215 0.7×	134 0.8×	18 0.3×	71 1.1×	30 0.7×	32	368
Yuko Maruyama Japan	11	118 0.4×	105 0.6×	17 0.3×	12 0.2×	49 1.2×	34	320
Wilson J. Heriot Australia	17	637 2.1×	445 2.6×	46 0.7×	60 1.0×	162 3.9×	37	851
Andrea D. Birnbaum United States	15	458 1.5×	55 0.3×	36 0.6×	54 0.9×	63 1.5×	31	635
Mustafa Iftikhar United States	12	335 1.1×	96 0.6×	28 0.4×	18 0.3×	135 3.2×	33	443
Preeti Patil Chhablani India	10	123 0.4×	80 0.5×	8 0.1×	96 1.5×	27 0.6×	26	311
Iason S. Mantagos United States	13	160 0.5×	222 1.3×	7 0.1×	64 1.0×	22 0.5×	43	498
Michael Stewart United States	16	297 1.0×	243 1.4×	10 0.2×	22 0.3×	73 1.7×	28	473
Olufunmilola A. Ogun Nigeria	10	85 0.3×	75 0.4×	13 0.2×	33 0.5×	55 1.3×	26	301
Brendan Moriarty United Kingdom	9	185 0.6×	91 0.5×	9 0.1×	41 0.7×	77 1.8×	17	381

Countries citing papers authored by Øystein Kalsnes Jørstad

Since Specialization

Citations

This map shows the geographic impact of Øystein Kalsnes Jørstad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Øystein Kalsnes Jørstad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Øystein Kalsnes Jørstad more than expected).

Fields of papers citing papers by Øystein Kalsnes Jørstad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Øystein Kalsnes Jørstad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Øystein Kalsnes Jørstad. The network helps show where Øystein Kalsnes Jørstad may publish in the future.

Co-authorship network of co-authors of Øystein Kalsnes Jørstad

This figure shows the co-authorship network connecting the top 25 collaborators of Øystein Kalsnes Jørstad. A scholar is included among the top collaborators of Øystein Kalsnes Jørstad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Øystein Kalsnes Jørstad. Øystein Kalsnes Jørstad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lund, Lars Christian, Martin Ernst, Vidar Hjellvik, et al.. (2025). Use of semaglutide and risk of non‐arteritic anterior ischemic optic neuropathy: A Danish–Norwegian cohort study. Diabetes Obesity and Metabolism. 27(6). 3094–3103. 14 indexed citations breakdown →

Austeng, Dordi, et al.. (2024). Validation of the European visual field standards for driving: A driving simulator‐based study. Acta Ophthalmologica. 103(2). 222–231.

Kristianslund, Olav, Goran Petrovski, Maurício Maia, et al.. (2023). Accuracy, Precision, and Residual Volume of Commonly Used Syringes for Intravitreal Injections and the Impact on Intraocular Pressure. Ophthalmology Retina. 7(10). 892–900. 7 indexed citations

Moe, Morten C., et al.. (2023). Intravitreal anti‐vascular endothelial growth factor therapy for retinal diseases in Norway from 2011 to 2021: A combined registry and survey study. Acta Ophthalmologica. 102(5). 544–554. 2 indexed citations

Melo, Gustavo Barreto, et al.. (2023). Accuracy and residual volume of intravitreal injection syringes in administration of very small volumes. Eye. 38(2). 395–396. 2 indexed citations

Jørstad, Øystein Kalsnes, et al.. (2023). Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties. International Journal of Retina and Vitreous. 9(1). 65–65. 6 indexed citations

Gjølberg, Torleif Tollefsrud, Rahel Frick, Stian Foss, et al.. (2022). Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-life. Communications Biology. 5(1). 832–832. 14 indexed citations

Jørstad, Øystein Kalsnes, Morten C. Moe, Goran Petrovski, et al.. (2022). Noninvasive Estimation of Pulsatile and Static Intracranial Pressure by Optical Coherence Tomography. Translational Vision Science & Technology. 11(1). 31–31. 7 indexed citations

Bathen, Marianne Etzelmüller, et al.. (2022). Retinal injuries in seven teenage boys from the same handheld laser. American Journal of Ophthalmology Case Reports. 27. 101596–101596.

10.

Moe, Morten C., et al.. (2022). Healthcare expenditure of intravitreal anti‐vascular endothelial growth factor inhibitors compared with dexamethasone implant for diabetic macular oedema. Acta Ophthalmologica. 100(8). e1630–e1640. 3 indexed citations

11.

Gjølberg, Torleif Tollefsrud, Gustavo Barreto Melo, Christine Probst, et al.. (2022). A Silicone Oil-Free Syringe Tailored for Intravitreal Injection of Biologics. Frontiers in Ophthalmology. 2. 882013–882013. 5 indexed citations

12.

Erichsen, Anne Kjersti, et al.. (2022). A novel homozygous variant in the SPG7 gene presenting with childhood optic nerve atrophy. American Journal of Ophthalmology Case Reports. 26. 101400–101400. 2 indexed citations

13.

Skogen, Karoline, et al.. (2021). Bilateral calcification of the optic nerve sheath: A diagnostic dilemma. American Journal of Ophthalmology Case Reports. 22. 101106–101106. 4 indexed citations

14.

Eidet, Jon Roger, Ole Kristoffer Olstad, Øystein Kalsnes Jørstad, et al.. (2021). The acute phase response protein SERPINA3 is increased in tear fluid from the unaffected eyes of patients with unilateral acute anterior uveitis. Journal of Ophthalmic Inflammation and Infection. 11(1). 19–19. 6 indexed citations

15.

Bragadóttir, Ragnheiður, et al.. (2020). Does Pharmaceutical Compounding of Vascular Endothelial Growth Factor Inhibitors for Intravitreal Use Alter the Risk of Post-injection Endophthalmitis?. Ocular Immunology and Inflammation. 30(3). 713–716. 7 indexed citations

16.

Jørstad, Øystein Kalsnes, et al.. (2020). Multiple Vitelliform Lesions as a Retinal Manifestation of Alport Syndrome. Case Reports in Ophthalmology. 11(1). 79–84. 2 indexed citations

17.

Jørstad, Øystein Kalsnes, et al.. (2020). The Value of Macular Optical Coherence Tomography in Watchful Waiting of Suprasellar Masses: A 2-Year Observational Study. Journal of Neuro-Ophthalmology. 41(4). e516–e522. 1 indexed citations

18.

Gjølberg, Torleif Tollefsrud, Stian Foss, Yvonne Andersson, et al.. (2019). A new method for pharmaceutical compounding and storage of anti-VEGF biologics for intravitreal use in silicone oil-free prefilled plastic syringes. Scientific Reports. 9(1). 18021–18021. 23 indexed citations

19.

Eidet, Jon Roger, et al.. (2019). Foster Kennedys syndrom. Tidsskrift for Den norske legeforening. 139(10). 2 indexed citations

20.

Jørstad, Øystein Kalsnes, et al.. (2018). Pharmaceutical compounding of aflibercept in prefilled syringes does not affect structural integrity, stability or VEGF and Fc binding properties. Scientific Reports. 8(1). 2101–2101. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact